Lincomycin hydrochloride anhydrous

This classification denotes a lincosamide antibiotic with the molecular formula C18H34N2O6S.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GCW8Y9936L, chemically known as d-erythro-.alpha.-d-galacto-octopyranoside, methyl 6,8-dideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, monohydrochloride, (2s-trans)-, but more generally known as lincomycin hydrochloride anhydrous, which bears US NIH Compound Identifier 64710. European Medicines Agency schedules lincomycin hydrochloride anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08517MIG. Most nations, for tariff purposes, schedule lincomycin hydrochloride anhydrous under HS 29419000. Lincomycin hydrochloride anhydrous bears US NLM identifiers UMLS ID C2983919 and NCI Concept Code C90876. SMILES: CCC[C@@H]1C[C@H](N(C1)C)C(=O)N[C@@H]([C@@H]2[C@@H]([C@@H]([C@H]([C@H](O2)SC)O)O)O)[C@@H](C)O.CL.